Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse

Cell stem cell(2020)10.1016/j.stem.2020.06.022Source: DataRank Database

BMI1 Inhibition Eliminates Residual Cancer Stem Cells after PD1 Blockade and Activates Antitumor Immunity to Prevent Metastasis and Relapse is a research paper published in Cell stem cell (2020). On theSindex it has a DataRank of 0. It has been cited 172 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access172 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 7.45)OA: bronzeTopics (52)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Wuchang Zhang ORCID,Cun‐Yu Wang ORCID,Lingfei Jia ORCID

Live enrichment

PubMed:32697949 OpenAlex:https://openalex.org/W3044095240

National Cancer Institute

Grant: R01CA236878

National Institutes of Health

Grant: 5R01DE015964-06

Molecular and Genetic Determinants of invasion in HNSCC

National Institutes of Health

Grant: 5R01CA236878-03

Molecular and Epigenetic Control of Wnt/b-catenin-mediated oncogenesis by KDM4B

NCI NIH HHS

Grant: P30 CA016042

NIDCR NIH HHS

Grant: R01 DE015964

NIDCR NIH HHS

Grant: R01 DE029173

FWCI

7.45

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttp://www.cell.com/article/S1934590920302897/pdf

publisherhttp://www.cell.com/article/S1934590920302897/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1934590920302897?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1934590920302897?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.stem.2020.06.022

Fields of Study

Cancer Cells and MetastasisCancer-related Molecular PathwaysCancer, Hypoxia, and Metabolism03 medical and health sciences0302 clinical medicineCD8-Positive T-LymphocytesCell Line, TumorHead and Neck NeoplasmsHumansNeoplasm Recurrence, LocalNeoplastic Stem CellsPolycomb Repressive Complex 1Squamous Cell Carcinoma of Head and Neck

MeSH Terms

Squamous Cell Carcinoma of Head and NeckHead and Neck NeoplasmsHumansNeoplasm Recurrence, LocalNeoplastic Stem CellsCD8-Positive T-LymphocytesCell Line, TumorPolycomb Repressive Complex 1

Keywords

BMI1Cancer researchCancer stem cellBlockadeBiologyHead and neck squamous-cell carcinomaImmune checkpointStem cellImmunologyCancerImmune systemHead and neck cancerImmunotherapyCell biologyReceptorPolycomb Repressive Complex 1Head and Neck NeoplasmsSquamous Cell Carcinoma of Head and NeckCell Line, TumorNeoplastic Stem CellsHumansCD8-Positive T-LymphocytesNeoplasm Recurrence, LocalCD8+ T cellsHNSCCPD1 blockadeantitumor immune responsecancer stem cellsinvasive growthmetastasissquamous cell carcinoma

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being